Autres langues Vanda Pharmaceuticals Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
4,62 ^USD	+3,12%		-9,59%	+9,48%

25/04	Shareholder Capital demande au conseil d'administration de Vanda Pharma de reconsidérer l'offre de Future Pak	RE
22/04	La Cour suprême des États-Unis rejette la demande de Vanda Pharmaceuticals concernant les brevets sur les médicaments contre les troubles du sommeil	RE

Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer	25/04
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals	25/04
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ ANDA Litigation	23/04
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation	23/04
Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court	22/04
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents	22/04
Butler Hall Capital urges Vanda to engage in sales discussions	19/04
Deals of the day-Mergers and acquisitions	17/04
Sector Update: Health Care Stocks Retreating Late Afternoon	17/04
Sector Update: Health Care Stocks Mixed Wednesday Afternoon	17/04
Sector Update: Health Care	17/04
Top Midday Gainers	17/04
Vanda Pharmaceuticals Adopts Stockholder Rights Plan; Shares Rise	17/04
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan	17/04
Vanda Pharmaceuticals' Board Rejects all Unsolicited Takeover Proposals From Future Pak	17/04
Vanda Pharmaceuticals rejects takeover proposal from Future Pak	17/04
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly	17/04
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak	17/04
Top Premarket Gainers	17/04
Vanda Pharmaceuticals Gets Acquisition Proposal From Future Pak; Shares Rise Pre-Bell	17/04

Aucun résultat pour cette recherche